- Home
- SA vs VCYT Comparison
SA vs VCYT Comparison
Compare SA & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SA | VCYT |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SA | VCYT |
|---|---|---|
| Price | $31.27 | $43.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $65.00 | $45.38 |
| AVG Volume (30 Days) | ★ 1.1M | 736.0K |
| Earning Date | 11-12-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $495,141,000.00 |
| Revenue This Year | N/A | $16.16 |
| Revenue Next Year | N/A | $10.92 |
| P/E Ratio | ★ N/A | $111.43 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $9.40 | $22.61 |
| 52 Week High | $31.87 | $50.71 |
Technical Indicators
Market Signals| Indicator | SA | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 60.22 | 53.81 |
| Support Level | $28.62 | $41.49 |
| Resistance Level | $30.82 | $43.05 |
| Average True Range (ATR) | 1.46 | 1.19 |
| MACD | -0.15 | -0.17 |
| Stochastic Oscillator | 70.32 | 81.47 |
Price Performance
Historical ComparisonAbout SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.